Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

Author： KHAN MISBAH H.   ALAM MURAD   YOO SIMON  

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.37, Iss.9, 2011-09, pp. : 1199-1209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acneiform folliculitis associated with epidermal growth factor receptor (EGFR) inhibitors requires sympathetic treatment of mild, as well as severe, symptoms

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer

By Agelaki Sofia   Georgoulias Vassilis  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 855-874

Informa Healthcare

Access to resources Recommend Favorite

Putting the Brakes on Cancer: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

By  

Pharmaceutical Innovation, Vol. 12, Iss. 1, 2002-12 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer

By Dancey Janet E.  

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1125-1138

Adis International

Access to resources Recommend Favorite

Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors

By  

Current Medicinal Chemistry, Vol. 20, Iss. 16, 2013-05 ,pp. : 2043-2067

Bentham Science Publishers

Access to resources Recommend Favorite